Facts about DES & breast cancer

Details

• Alternative Title:
  Facts about DES and breast cancer
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  DES - a synthetic estrogen that was prescribed to pregnant women during 1938-1971 to prevent miscarriages or premature delivery - has been linked to several health risks. Included among these, is an increased risk of breast cancer among women who were prescribed DES while pregnant and DES Daughters - women who were exposed to DES in the womb.
  
  Research available through CDC's DES Update currently confirms the following facts pertaining to the affect of DES exposure on a woman's risk for breast cancer.
  
  Publication date from document properties.
  
  DES&BreastCancerFS.pdf
  
  
• Subjects:
  Breast Neoplasms Breast Neoplasms / Chemically Induced Diethylstilbestrol Diethylstilbestrol / Adverse Effects Pregnancy Prenatal Exposure Delayed Effects Prenatal Exposure Delayed Effects / Chemically Induced
• Document Type:
  Text
• Genre:
  Pamphlet (or booklet)
• Pages in Document:
  1 unnumbered page
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:2249842eb600aee8915aa9e9784129d7aedbfbe374ce8bf2e246d9a0fa4ae09347620b54bac9a470e8822a5deaa548c246822d2f69c948a1d46f1a33be21d85d
• Download URL:
  https://stacks.cdc.gov/view/cdc/41052/cdc_41052_DS1.pdf
• File Type:
  [PDF - 16.67 KB ]